相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Chimeric Fusion Proteins Used for Therapy: Indications, Mechanisms, and Safety
Brian A. Baldo
DRUG SAFETY (2015)
Reductions in synaptic proteins and selective alteration of prepulse inhibition in male C57BL/6 mice after postnatal administration of a VIP receptor (VIPR2) agonist
Yukio Ago et al.
PSYCHOPHARMACOLOGY (2015)
Fc fusion as a platform technology: potential for modulating immunogenicity
Ditza Levin et al.
TRENDS IN BIOTECHNOLOGY (2015)
Half-life extension technologies for haemostatic agents
Pier Mannuccio Mannucci
THROMBOSIS AND HAEMOSTASIS (2015)
Co-opting Biology to Deliver Drugs
Parisa Yousefpour et al.
BIOTECHNOLOGY AND BIOENGINEERING (2014)
A von Willebrand factor fragment containing the D′D3 domains is sufficient to stabilize coagulation factor VIII in mice
Andrew Yee et al.
BLOOD (2014)
GSK2374697, a Novel Albumin-Binding Domain Antibody (AlbudAb), Extends Systemic Exposure of Exendin-4: First Study in Humans-PK/PD and Safety
R. L. O'Connor-Semmes et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
The Effects of Fusion Structure on the Expression and Bioactivity of Human Brain Natriuretic Peptide (BNP) Albumin Fusion Proteins
Yuedi Ding et al.
CURRENT PHARMACEUTICAL BIOTECHNOLOGY (2014)
Proinsulin-Transferrin Fusion Protein as a Novel Long-Acting Insulin Analog for the Inhibition of Hepatic Glucose Production
Yan Wang et al.
DIABETES (2014)
Changing paradigm of prophylaxis with longer acting factor concentrates
M. Carcao
HAEMOPHILIA (2014)
Enhanced in Vivo Efficacy of a Type I Interferon Superagonist with Extended Plasma Half-life in a Mouse Model of Multiple Sclerosis
Daniel Harari et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Extending Serum Half-life of Albumin by Engineering Neonatal Fc Receptor ( FcRn) Binding
Jan Terje Andersen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Pharmacological characteristics of a novel, recombinant fusion protein linking coagulation factor VIIa with albumin (rVIIa-FP)
S. Zollner et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Differential intracellular signalling properties of the growth hormone receptor induced by the activation of an anti-GHR antibody
Hainan Lan et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2014)
Characterisation of a Novel Fc Conjugate of Macrophage Colony-stimulating Factor
Deborah J. Gow et al.
MOLECULAR THERAPY (2014)
A fusion protein derived from plants holds promising potential as a new oral therapy for type 2 diabetes
Jeehye Choi et al.
PLANT BIOTECHNOLOGY JOURNAL (2014)
Comparative Study of Somatostatin-Human Serum Albumin Fusion Proteins and Natural Somatostatin on Receptor Binding, Internalization and Activation
Ying Peng et al.
PLOS ONE (2014)
Fusion of a Short Peptide that Binds Immunoglobulin G to a Recombinant Protein Substantially Increases Its Plasma Half-Life in Mice
Jonathan T. Sockolosky et al.
PLOS ONE (2014)
Fusion protein linkers: Property, design and functionality
Xiaoying Chen et al.
ADVANCED DRUG DELIVERY REVIEWS (2013)
Albumin as a versatile platform for drug half-life extension
Darrell Sleep et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2013)
Recent progress and future options in the development of GLP-1 receptor agonists for the treatment of diabesity
Martin Lorenz et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)
Novel AGLP-1 albumin fusion protein as a long-lasting agent for type 2 diabetes
Yong-Mo Kim et al.
BMB REPORTS (2013)
Conjugation of hyaluronan to proteins
Anna Mero et al.
CARBOHYDRATE POLYMERS (2013)
Pharmacokinetics and Pharmacokinetic-Pharmacodynamic Correlations of Therapeutic Peptides
Lei Diao et al.
CLINICAL PHARMACOKINETICS (2013)
Neonatal Fc Receptor and its Role in the Absorption, Distribution, Metabolism and Excretion of Immunoglobulin G-Based Biotherapeutics
Craig Giragossian et al.
CURRENT DRUG METABOLISM (2013)
A Long-Acting Human Growth Hormone With Delayed Clearance (VRS-317): Results of a Double-Blind, Placebo-Controlled, Single Ascending Dose Study in Growth Hormone-Deficient Adults
Kevin C. J. Yuen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Phase 3 Study of Recombinant Factor IX Fc Fusion Protein in Hemophilia B
Jerry S. Powell et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
PASylation: a biological alternative to PEGylation for extending the plasma half-life of pharmaceutically active proteins
Martin Schlapschy et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2013)
Extending the pharmacokinetic half-life of coagulation factors by fusion to recombinant albumin
Hubert J. Metzner et al.
THROMBOSIS AND HAEMOSTASIS (2013)
Innovative coagulation factors: albumin fusion technology and recombinant single-chain factor VIII
Stefan Schulte
THROMBOSIS RESEARCH (2013)
Building better drugs: developing and regulating engineered therapeutic proteins
Chava Kimchi-Sarfaty et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2013)
Recombinant factor IX-Fc fusion protein (rFIXFc) demonstrates safety and prolonged activity in a phase 1/2a study in hemophilia B patients
Amy D. Shapiro et al.
BLOOD (2012)
Safety and prolonged activity of recombinant factor VIII Fc fusion protein in hemophilia A patients
Jerry S. Powell et al.
BLOOD (2012)
Safety and pharmacokinetics of a novel recombinant fusion protein linking coagulation factor IX with albumin (rIX-FP) in hemophilia B patients
Elena Santagostino et al.
BLOOD (2012)
Fc-fusion proteins: new developments and future perspectives
Daniel M. Czajkowsky et al.
EMBO MOLECULAR MEDICINE (2012)
A novel long-acting human growth hormone fusion protein (vrs-317): enhanced in vivo potency and half-life
Jeffrey L. Cleland et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2012)
Improved kinetics of rIX-FP, a recombinant fusion protein linking factor IX with albumin, in cynomolgus monkeys and hemophilia B dogs
M. W. Nolte et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Human serum albumin: From bench to bedside
Gabriella Fanali et al.
MOLECULAR ASPECTS OF MEDICINE (2012)
Antitumor Activity of a Novel Bispecific Antibody That Targets the ErbB2/ErbB3 Oncogenic Unit and Inhibits Heregulin-Induced Activation of ErbB3
Charlotte F. McDonagh et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Peptibodies A flexible alternative format to antibodies
Grant Shimamoto et al.
MABS (2012)
GLP2-2G-XTEN: A Pharmaceutical Protein with Improved Serum Half-Life and Efficacy in a Rat Crohn's Disease Model
Susan E. Alters et al.
PLOS ONE (2012)
Corifollitropin Alfa A Review of its Use in Controlled Ovarian Stimulation for Assisted Reproduction
Jamie D. Croxtall et al.
BIODRUGS (2011)
Extending Half-life by Indirect Targeting of the Neonatal Fc Receptor (FcRn) Using a Minimal Albumin Binding Domain
Jan Terje Andersen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Receptor-mediated activation of a proinsulin-transferrin fusion protein in hepatoma cells
Yan Wang et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Single Dose GLP-1-Tf Ameliorates Myocardial Ischemia/Reperfusion Injury
Muneaki Matsubara et al.
JOURNAL OF SURGICAL RESEARCH (2011)
Effects of Receptor Binding on Plasma Half-Life of Bifunctional Transferrin Fusion Proteins
Xiaoying Chen et al.
MOLECULAR PHARMACEUTICS (2011)
Biosimilar, biobetter and next generation therapeutic antibodies
Alain Beck
MABS (2011)
Therapeutic Fc-fusion proteins and peptides as successful alternatives to antibodies
Alain Beck et al.
MABS (2011)
ELPylated anti-human TNF therapeutic single-domain antibodies for prevention of lethal septic shock
Udo Conrad et al.
PLANT BIOTECHNOLOGY JOURNAL (2011)
PEGylation of therapeutic proteins
Simona Jevsevar et al.
BIOTECHNOLOGY JOURNAL (2010)
Engineering and characterization of the long-acting glucagon-like peptide-1 analogue LY2189265, an Fc fusion protein
Wolfgang Glaesner et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2010)
Designing a Long-Acting Human Growth Hormone (hGH) by Fusing the Carboxyl-Terminal Peptide of Human Chorionic Gonadotropin β-Subunit to the Coding Sequence of hGH
Fuad Fares et al.
ENDOCRINOLOGY (2010)
Engineering a pharmacologically superior form of granulocyte-colony-stimulating factor by fusion with gelatin-like-protein polymer
Yan-Shan Huang et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2010)
Albinterferon Alfa-2b Was Not Inferior to Pegylated Interferon-α in a Randomized Trial of Patients With Chronic Hepatitis C Virus Genotype 2 or 3
David R. Nelson et al.
GASTROENTEROLOGY (2010)
Importance of Neonatal FcR in Regulating the Serum Half-Life of Therapeutic Proteins Containing the Fc Domain of Human IgG1: A Comparative Study of the Affinity of Monoclonal Antibodies and Fc-Fusion Proteins to Human Neonatal FcR
Takuo Suzuki et al.
JOURNAL OF IMMUNOLOGY (2010)
Transferrin Fusion Technology: A Novel Approach to Prolonging Biological Half-Life of Insulinotropic Peptides
Byung-Joon Kim et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
Gcg-XTEN: An Improved Glucagon Capable of Preventing Hypoglycemia without Increasing Baseline Blood Glucose
Nathan C. Geething et al.
PLOS ONE (2010)
Novel GLP-1 Fusion Chimera as Potent Long Acting GLP-1 Receptor Agonist
Qinghua Wang et al.
PLOS ONE (2010)
Elastin-like polypeptides revolutionize recombinant protein expression and their biomedical application
Doreen M. Floss et al.
TRENDS IN BIOTECHNOLOGY (2010)
Strategies to Extend Plasma Half-Lives of Recombinant Antibodies
Roland E. Kontermann
BIODRUGS (2009)
Receptor-Fc fusion therapeutics, traps, and MIMETIBODY™ technology
Chichi Huang
CURRENT OPINION IN BIOTECHNOLOGY (2009)
Emerging PEGylated drugs
Jung Seok Kang et al.
EXPERT OPINION ON EMERGING DRUGS (2009)
A recombinant polypeptide extends the in vivo half-life of peptides and proteins in a tunable manner
Volker Schellenberger et al.
NATURE BIOTECHNOLOGY (2009)
Immune and non-immune functions of the (not so) neonatal Fc receptor, FcRn
Kristi Baker et al.
SEMINARS IN IMMUNOPATHOLOGY (2009)
Half-life extension through albumin fusion technologies
Stefan Schulte
THROMBOSIS RESEARCH (2009)
Mechanisms for cytotoxic effects of anti-tumor necrosis factor agents on transmembrane tumor necrosis factor α-expressing cells
Hiroki Mitoma et al.
ARTHRITIS AND RHEUMATISM (2008)
CNTO 530:: Molecular pharmacology in human UT-7EPO cells and pharmacokinetics and pharmacodynamics in mice
P. J. Bugelski et al.
JOURNAL OF BIOTECHNOLOGY (2008)
Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles
Felix Kratz
JOURNAL OF CONTROLLED RELEASE (2008)
Increasing the homogeneity, stability and activity of human serum albumin and interferon-alpha 2b fusion protein by linker engineering
Hong Liang Zhao et al.
PROTEIN EXPRESSION AND PURIFICATION (2008)
PEGylation of somatropin (recombinant human growth hormone): Impact on its clearance in humans
R. Webster et al.
XENOBIOTICA (2008)
Albinterferon α-2b:: a genetic fusion protein for the treatment of chronic hepatitis C
G. Mani Subramanian et al.
NATURE BIOTECHNOLOGY (2007)
The physiology of glucagon-like peptide 1
Jens Juul Holst
PHYSIOLOGICAL REVIEWS (2007)
Development of a long-acting erythropoietin by fusing the carboxyl-terminal peptide of human chorionic gonadotropin β-subunit to the coding sequence of human erythropoietin
Fuad Fares et al.
ENDOCRINOLOGY (2007)
Fusion of a recombinant antibody fragment with a homo-amino-acid polymer: effects on biophysical properties and prolonged plasma half-life
Martin Schlapschy et al.
PROTEIN ENGINEERING DESIGN & SELECTION (2007)
Chemically programmed antibodies:: Endothelin receptor targeting CovX-Bodies™
Venkata R. Doppalapudi et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)
Targeting tissue factor for immunotherapy of choroidal neovascularization by intravitreal delivery of factor VII-Fc chimeric antibody
Tongalp H. Tezel et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2007)
FcRn: the neonatal Fc receptor comes of age
Derry C. Roopenian et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Gut peptides in the regulation of food intake and energy homeostasis
Kevin G. Murphy et al.
ENDOCRINE REVIEWS (2006)
The crystal structure of iron-free human serum transferrin provides insight into inter-lobe communication and receptor binding
Jeremy Wally et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Albumin binding to FcRn: Distinct from the FcRn-IgG interaction
C Chaudhury et al.
BIOCHEMISTRY (2006)
Improving the oral efficacy of recombinant granulocyte colony-stimulating factor and transferrin fusion protein by spacer optimization
Yun Bai et al.
PHARMACEUTICAL RESEARCH (2006)
Monomeric Fc fusions - Impact on pharmacokinetic and biological activity of protein therapeutics
Jennifer A. Dumont et al.
BIODRUGS (2006)
Strategies to improve plasma half life time of peptide and protein drugs
M. Werle et al.
AMINO ACIDS (2006)
Improving the therapeutic efficacy of peptides and proteins: A role for polysialic acids
G Gregoriadis et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2005)
Recombinant granulocyte colony-stimulating factor-transferrin fusion protein as an oral myelopoietic agent
Y Bai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Pharmacokinetic aspects of biotechnology products
L Tang et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2004)
Pharmacokinetic and biodistribution properties of poly(ethylene glycol)-protein conjugates
P Caliceti et al.
ADVANCED DRUG DELIVERY REVIEWS (2003)
The major histocompatibility complex-related Fc receptor for IgG (FcRn) binds albumin and prolongs its lifespan
C Chaudhury et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Albutropin: a growth hormone-albumin fusion with improved pharmacokinetics and pharmacodynamics in rats and monkeys
BL Osborn et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2002)
Albugranin™, a recombinant human granulocyte colony stimulating factor (G-CSF) genetically fused to recombinant human albumin induces prolonged myelopoietic effects in mice and monkeys
W Halpern et al.
PHARMACEUTICAL RESEARCH (2002)
VEGF-Trap: A VEGF blocker with potent antitumor effects
J Holash et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Single dose pharmacokinetics and effects on follicular growth and serum hormones of a long-acting recombinant FSH preparation (FSH-CTP) in healthy pituitary-suppressed females
IJM Duijkers et al.
HUMAN REPRODUCTION (2002)
Pharmacokinetics and pharmacodynamics of single-chain recombinant human follicle-stimulating hormone containing the human chorionic gonadotropin carboxyterminal peptide in the rhesus monkey
J Klein et al.
FERTILITY AND STERILITY (2002)
Transcytosis and catabolism of antibody
V Ghetie et al.
IMMUNOLOGIC RESEARCH (2002)
Prolonged in vivo residence times of antibody fragments associated with albumin
BJ Smith et al.
BIOCONJUGATE CHEMISTRY (2001)
分享论文
